UK Predictive Genetic Testing and Consumer Wellness Genomics Market Research Report By Test Type (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, Others), and By Setting Type (Proteomic Testing, Metabolic Testing, Genomic Testing)- Forecast to 2035

UK Predictive Genetic Testing and Consumer Wellness Genomics Market Overview

As per MRFR analysis, the UK Predictive Genetic Testing and Consumer Wellness Genomics Market Size was estimated at 74.9 (USD Million) in 2023.The UK Predictive Genetic Testing and Consumer Wellness Genomics Market is expected to grow from 83.29(USD Million) in 2024 to 947.88 (USD Million) by 2035. The UK Predictive Genetic Testing and Consumer Wellness Genomics Market CAGR (growth rate) is expected to be around 24.743% during the forecast period (2025 - 2035).

Key UK Predictive Genetic Testing and Consumer Wellness Genomics Market Trends Highlighted

The market for consumer wellness genomics and predictive genetic testing in the UK is expanding significantly due to consumers' growing acceptance and understanding of genetic testing. The UK government's efforts to enhance healthcare through personalised medicine and genetic research provide considerable support for this trend.

One of the main factors driving the market is the NHS genetic Medicine Service's growth, which encourages more people to use genetic testing for health risk assessments and management. Furthermore, the general public now has easier access to these services due to technological developments and decreased genetic testing prices.

There are numerous chances to investigate in this quickly changing environment. For example, businesses have an increasing opportunity to provide novel and focused health products based on people's genetic profiles as the market grows.

Partnerships between digital firms, medical facilities, and academic organisations can improve product offers even more and promote the broader use of genetic testing methods. Additionally, there is a chance to raise knowledge and understanding of the advantages and restrictions of genetic testing, assisting customers in making well-informed health-related judgements.

Consumers in the UK are becoming more interested in proactive wellness methods, indicating a shift towards preventative healthcare. The growth of direct-to-consumer genetic testing services, which enable people to take control of their health and well-being, is indicative of this.

The market is seeing a rise in the incorporation of lifestyle and wellness recommendations based on genetic data, coinciding with the increased emphasis on personalised health.

The UK market is well-positioned for future advancements and improvements in consumer wellness genomics thanks to its emphasis on holistic health management. All things considered, the changing environment is expected to offer all-encompassing solutions that satisfy the rising demand from customers for individualised medical treatment.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

UK Predictive Genetic Testing and Consumer Wellness Genomics Market Drivers

Rising Awareness of Genetic Disorders

The growing awareness of genetic disorders in the UK is a significant driver for the UK Predictive Genetic Testing and Consumer Wellness Genomics Market. According to estimates from the National Health Service (NHS), about 1 in 17 people are affected by a genetic disorder at some point in their lives, which translates to millions of individuals who could benefit from predictive genetic testing.

This increasing recognition not only promotes a heightened demand for genetic testing services but also encourages advancements in Research and Development (R&D) for new testing technologies.

Established organizations such as Genomics England work closely with the NHS to integrate genomic medicine into routine healthcare, driving the uptake of predictive genetic testing. They have already sequenced over 100,000 genomes, highlighting the commitment to using genetic data to understand and prevent diseases more effectively.

Technological Advancements in Genetic Testing

Innovations in genetic testing technology, including next-generation sequencing (NGS) techniques, are propelling growth in the UK Predictive Genetic Testing and Consumer Wellness Genomics Market. Recent advances have significantly reduced the costs and time associated with genetic testing, making it more accessible to the general population.

For example, the price of whole genome sequencing has decreased by over 90% in the past decade, according to the UK Genome Partnership.

Such affordability has led to a broader adoption of predictive testing among consumers, which can lead to early intervention and personalized healthcare solutions. Organizations like Illumina have been pivotal in driving down costs through continuous innovation, cementing the UK as a global leader in genomic research and testing.

Government Initiatives and Funding

Government policies in the UK that support genomic research and public health initiatives are a critical driver for the UK Predictive Genetic Testing and Consumer Wellness Genomics Market. The UK Government’s Genomic Strategy aims to integrate genomic data into healthcare to improve patient outcomes.

With an investment of 200 million in the last five years into various genomics projects, the government is fostering an environment conducive to R&D and innovation.

By establishing the NHS Genomic Medicine Service and the NHS Long Term Plan, which prioritize genomic testing for various diseases, the UK is advancing the implementation of predictive genetic testing to empower individuals. This strong governmental backing encourages private sector participation and attracts investment from firms dedicated to enhancing consumer wellness through genomics.

UK Predictive Genetic Testing and Consumer Wellness Genomics Market Segment Insights

Predictive Genetic Testing and Consumer Wellness Genomics Market Test Type Insights

The UK Predictive Genetic Testing and Consumer Wellness Genomics Market has been experiencing remarkable growth, particularly in the Test Type segment, which encompasses various categories such as Predictive Testing, Consumer Genomics, and Wellness Genomics.

Predictive Testing has gained considerable traction as individuals seek to understand their genetic predispositions to certain diseases and health conditions, assisting in proactive healthcare decisions. The continuous advancements in technology, coupled with increased awareness and accessibility of genetic testing, have significantly driven the demand for this segment.

In the realm of Consumer Genomics, there is a growing interest among consumers for personalized health insights, which has led to a rise in direct-to-consumer genetic tests. These tests empower individuals to make informed lifestyle choices by providing genetic information in an easily understandable format.

As for Wellness Genomics, it focuses on preventive care and optimizing overall health through genetic insights. This segment is increasingly crucial, as consumers are shifting their focus from reactive to preventive health strategies. The growing adoption of these genomic services indicates a shift in consumer behavior towards a more personalized medical approach.

Moreover, favorable government initiatives and support in the UK for genomic research further enhance the development of these segments. The integration of artificial intelligence and machine learning in interpreting genetic data is also emerging as a significant trend, streamlining the process and boosting the efficiency of genetic testing.

Overall, the Test Type segment within the UK Predictive Genetic Testing and Consumer Wellness Genomics Market is illustrative of a transformative shift in healthcare, driven by technological advancements, consumer demand for personalized services, and a proactive approach to health and wellness.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Predictive Genetic Testing and Consumer Wellness Genomics Market Application Insights

The UK Predictive Genetic Testing and Consumer Wellness Genomics Market has seen substantial growth, particularly evident within the Application segment, which encompasses a variety of critical health conditions. Applications such as Breast and Ovarian Cancer screening are essential, as they cater to early detection, significantly enhancing patient outcomes and treatment efficacy.

Cardiovascular Screening is increasingly vital as heart disease remains one of the leading health concerns in the UK, driving demand for proactive health management solutions. Diabetic Screening and Monitoring are also gaining traction, empowered by the rising prevalence of diabetes in the population, making ongoing monitoring essential for health stability.

Colon Cancer screening holds significant importance in preventive healthcare, considering the rising incidence rates, while disorders like Parkinsonism and Alzheimer’s Disease require innovative genetics-based assessments to prepare for future healthcare needs.

Urologic Screening, particularly concerning Prostate Cancer, has established itself as a prominent area, ensuring earlier intervention strategies are in place. Orthopedic and Musculoskeletal applications are also emerging, reflecting growing awareness around genetic predispositions to conditions such as osteoporosis.

Diversification into these various applications not only addresses the health concerns of the UK population but also underscores the advancements in technology and genetic testing capabilities that are shaping personalized healthcare pathways.

Predictive Genetic Testing and Consumer Wellness Genomics Market Setting Type Insights

The UK Predictive Genetic Testing and Consumer Wellness Genomics Market is witnessing significant developments in the Setting Type segment, which includes diverse areas such as Proteomic Testing, Metabolic Testing, and Genomic Testing.

This segment is crucial for advancing personalized medicine, allowing healthcare providers to offer tailored treatments based on the unique genetic makeup of individuals. Proteomic Testing is becoming increasingly important as it provides insights into proteins that play a vital role in health and disease, offering opportunities for early diagnostic capabilities and monitoring treatment efficacy.

Metabolic Testing offers vital information on metabolic pathways, aiding in the identification of risk factors and the development of personalized dietary and lifestyle recommendations. Meanwhile, Genomic Testing remains a dominant force, empowering consumers with knowledge about genetic predispositions, thus guiding preventive healthcare decisions and promoting wellness.

Collectively, these components of the Setting Type segment contribute significantly to the growth trajectory of the UK Predictive Genetic Testing and Consumer Wellness Genomics Market, driven by increasing consumer awareness, technological advancements, and a growing emphasis on preventive healthcare solutions.

The focus on precision in testing methods aligns with governmental support for genomics and health initiatives, paving the way for improved health outcomes and expanded market growth.

UK Predictive Genetic Testing and Consumer Wellness Genomics Market Key Players and Competitive Insights

The UK Predictive Genetic Testing and Consumer Wellness Genomics Market has been gaining traction as advancements in genomic technologies open new avenues for personalized medicine and preventive care. The competitive landscape is characterized by a mix of established players and emerging innovators.

Numerous factors contribute to this market's dynamism, including growing consumer awareness of genetic predispositions to health conditions, advancements in sequencing technologies, and the increasing demand for personalized health care solutions.

Companies in this market aim to capitalize on the trends surrounding wellness and preventive health through genetic testing services, which not only provide valuable insights into individual health risks but also cater to a population that is becoming increasingly health-conscious.

The competitive dynamics show a strong inclination toward innovation, emphasizing how organizations are racing to develop more accurate, affordable, and accessible testing solutions tailored to diverse consumer needs.

Genomic Health has established a noteworthy presence in the UK Predictive Genetic Testing and Consumer Wellness Genomics Market by focusing on the intersection of genomics and clinical care. The company's strengths lie in its innovative approach, which merges genomic insights with actionable health strategies, thereby empowering patients to make informed decisions concerning their health.

Genomic Health's participation in this market is reinforced by collaborations with healthcare providers and research institutions, thereby enhancing its credibility and outreach. Additionally, the company’s commitment to research and development ensures a continuous stream of cutting-edge genomic tests.

This forward-thinking focus has solidified Genomic Health's standing as a leader in providing accessible and reliable predictive genetic testing solutions, making it a key player in the UK sector. Complete Genomics, another significant contributor to the UK Predictive Genetic Testing and Consumer Wellness Genomics Market, specializes in sequencing services that are crucial for genetic analysis and research.

The company's primary focus is on delivering high-quality genomic data through efficient and state-of-the-art sequencing platforms, which cater to both healthcare providers and researchers. Complete Genomics has strategically positioned itself in the market through partnerships and collaborations that facilitate the integration of genomic data into existing healthcare frameworks.

The company offers various services, from whole-genome sequencing to personalized genomic health reports, reflecting its commitment to enhancing consumer wellness.

Additionally, the ongoing focus on mergers and acquisitions enables Complete Genomics to broaden its service offerings, strengthen its technological capabilities, and significantly enhance its market presence in the UK, thus ensuring that it remains an influential entity in the competitive landscape of predictive genetic testing and consumer wellness genomics.

Key Companies in the UK Predictive Genetic Testing and Consumer Wellness Genomics Market Include:

• Genomic Health


• Complete Genomics


• Decipher Genomics


• Invitae


• Fulgent Genetics


• Gene by Gene


• Pathway Genomics


• MyHeritage


• Dante Labs


• HealthTell


• Illumina


• GenoMe


• Color Genomics


• Ancestry


• 23andMe

UK Predictive Genetic Testing and Consumer Wellness Genomics Market Developments

Recent developments in the UK Predictive Genetic Testing and Consumer Wellness Genomics Market indicate a growing interest among consumers in personal genomics and health insights. Companies like MyHeritage and Ancestry are expanding their offerings, with MyHeritage recently enhancing its health feature to include more actionable insights as of September 2023.

Additionally, Illumina continues to lead in the sequencing technology domain, enhancing accessibility to genetic testing across different demographics, which is vital in promoting preventive healthcare measures. Notably, in October 2023, Invitae announced a collaboration with a UK-based healthcare provider to facilitate broader use of their genetic testing services, focusing on hereditary cancer.

The market has experienced significant growth, attributed to an increase in consumer awareness about genetic predisposition to various health conditions and wellness genomics. Over the past two years, advancements in technology have made genetic testing more cost-effective and reliable.

In terms of mergers and acquisitions, Fulgent Genetics completed their acquisition of Gene by Gene in July 2022, thus expanding their offerings in consumer genomics significantly, which aligns with the growing trend of personalized healthcare solutions in the UK.

UK Predictive Genetic Testing and Consumer Wellness Genomics Market Segmentation Insights

Predictive Genetic Testing and Consumer Wellness Genomics Market Test Type Outlook

• Predictive Testing


• Consumer Genomics


• Wellness Genomics

Predictive Genetic Testing and Consumer Wellness Genomics Market Application Outlook

• Breast & Ovarian Cancer


• Cardiovascular Screening


• Diabetic Screening & Monitoring


• Colon Cancer


• Parkinsonism/Alzheimer’s Disease


• Urologic Screening/Prostate Cancer Screening


• Orthopedic & Musculoskeletal


• Others

Predictive Genetic Testing and Consumer Wellness Genomics Market Setting Type Outlook

• Proteomic Testing


• Metabolic Testing


• Genomic Testing

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	74.9(USD Million)
MARKET SIZE 2024	83.29(USD Million)
MARKET SIZE 2035	947.88(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	24.743% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Genomic Health, Complete Genomics, Decipher Genomics, Invitae, Fulgent Genetics, Gene by Gene, Pathway Genomics, MyHeritage, Dante Labs, HealthTell, Illumina, GenoMe, Color Genomics, Ancestry, 23andMe
SEGMENTS COVERED	Test Type, Application, Setting Type
KEY MARKET OPPORTUNITIES	Personalized health insights demand, Rising consumer awareness and education, Increased accessibility to testing services, Growth in telehealth and digital platforms, Expansion of wellness-focused genetic services
KEY MARKET DYNAMICS	technological advancements, growing consumer awareness, regulatory challenges, privacy concerns, increasing healthcare costs
COUNTRIES COVERED	UK